Thanks very much. Well, I think it is important that we set out those national optimal pathways, and they have been developed for different tumour sites. And what we're trying to do is to make sure that we have value-based intervention. Of course, we have a unique approach in Wales, in the sense that we have a single, unified waiting time, which is different from the way they do it in England.

So, there are different kinds of cancers, and certainly when it comes to pancreatic cancer, for example, it's one of the six least survivable cancers. It is important that people understand that there are prescriptions, like pancreatic enzyme replacement therapy, which are available for all health boards in Wales, and they should apply that locally. So, where it is available, part of what we're trying to do is to disseminate awareness and produce materials to inform clinicians throughout Wales of the importance of prescribing the appropriate medicines. So, I hope that gives some clarification.